Home 
Bratislava Medical Journal 2019 Bratislava Medical Journal Vol.120, No.5, p.344–348, 2019
Bratislava Medical Journal 2019 Bratislava Medical Journal Vol.120, No.5, p.344–348, 2019
Journal info
|
||||
Select Journal
Journals
Bratislava Medical Journal 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Endocrine Regulations General Physiology and Biophysics Neoplasma Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Bratislava Medical Journal Vol.120, No.5, p.344–348, 2019 |
||
| Title: The relationship between plasma microRNAs and serum trace elements levels in primary hyperlipidemia | ||
| Author: F. H. Yerlikaya, U. Can, M. S. Alpaydin, A. Aribas | ||
| Abstract: OBJECTIVES: The aim of the study was to investigate the relationship between plasma microRNA expression levels, which are associated with lipid metabolism and serum trace element levels in patients with primary hyperlipidemia. METHODS: This study was performed on 46 (21M / 25F) primary hyperlipidemia patients aged 25–65 years and 37 (18 M/19 F) healthy people aged 25–65 years. RESULTS: The following miRNAs were upregulated: miR-33a-5p, miR-370-5p, miR-378a-3p, miR-27a-3p, miR-27a-5p and miR-335-5p. Additionally, the levels of Co (p < 0.001), Ni (p < 0.01), Cd (p < 0.001) were significantly higher and the level of Cr (p < 0.01), Fe (p < 0.05), Mn (p < 0.01), Se (p < 0.001) and Mo (p < 0.001) was significantly lower in the primary hyperlipidemic patients compared to the healthy people . Also, miR-33a-5p was negatively correlated with serum Cr levels in patients with primary hyperlipidemia (r = –0.376, p < 0.05). CONCLUSIONS: Our study demonstrates that miR-33a-5p and Cr element may regulate abnormal lipid homeostasis. Also, miR-370, miR-378, miR-27-a and miR-335 might aid in the identification of new therapies to treat patients with primary hyperlipidemia (Tab. 3, Ref. 36). |
||
| Keywords: primary hyperlipidemia, microRNA, trace elements | ||
| Published online: 21-May-2019 | ||
| Year: 2019, Volume: 120, Issue: 5 | Page From: 344, Page To: 348 | |
| doi:10.4149/BLL_2019_056 |
||
|
|
 download file |
|